NCT07685405Recruiting
Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas
Feasibility Study for the Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas
Source: ClinicalTrials.gov · Last updated 6 Jul 2026
Brief summary (registry, in English)
The study involves blood samples from patients with Ewing's sarcoma to identify circulating biomarkers as a tool for the preclinical validation of innovative therapeutic approaches
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 16 (estimated)
- First submitted
- 29 Jun 2026
- Start date
- 15 Apr 2026
- Primary completion date
- 30 Apr 2028
- Lead sponsor
- Istituto Ortopedico Rizzoli
- Diseases
- Childhood cancers, Sarcoma
- NCT number
- NCT07685405
What you commit to
- Study type: Observational
- Planned participants: 16
- From 15 Apr 2026 to the primary completion date, 30 Apr 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients who do not meet all inclusion criteria
- \-
Who the study is looking for
- Male and female patients of any age diagnosed with Ewing sarcoma.
- Signed, study-specific informed consent form for the BIOVES study (cancer patients)
- Male and female patients of legal age without a cancer diagnosis.
- Signed, study-specific informed consent form for the BIOVES study (non-cancer patients)
Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istituto ortopedico Rizzoli Laboratorio di Ricerc Oncologica e Genomica funzioanle Coordinator of this site? Confirm its status | Bologna | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.